Investing.com -- Dyne Therapeutics, Inc. (Nasdaq:DYN) stock fell 23% after the company announced an updated plan for obtaining U.S. Accelerated Approval for DYNE-101 in myotonic dystrophy type 1 (DM1) ...

Rosenthal said the Giants’ history of swinging and missing on high-profile sluggers — specifically naming the missed trade ...

A Spanish court has convicted four people who hung an effigy of Real Madrid star Vinícius Júnior off a highway bridge two years ago, the league said on Monday. The defendants were ...

Understanding the distinction between standalone and consolidated financial results is vital for investors. Standalone ...

Stay updated with the latest stock market news and live updates. Get real-time insights on Sensex Today, Nifty Live, stock market today, IPO news and more on Business Standard.

Charles Smith, 87, applied to hundreds of jobs in his 80s before landing one at his county's Office of Aging, which pays ...

Federal prosecutors said Kris Bortnovsky, co-founder of Sakal Capital Management, earned over $4 million by placing illegal ...

Prince Harry and Meghan Markle’s latest recruit previously managed worldwide publicity for Netflix’s drama series The Crown.

In the current Australian market, energy stocks have been in focus due to geopolitical tensions affecting Brent Crude prices, while other sectors like metals and mining have experienced volatility.

Currently, Collegium Pharmaceutical shares are trading down 0.0%, priced at $29.69 during Thursday's morning. This values MD's 15,000 shares at $243,600.

After closing at Rs 127.15 on Thursday, the shares of Kellton Tech Solutions, a small-cap IT company, started higher on the ...